TransMedics Group (NasdaqGM:TMDX) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Company ParticipantsAllen Gong - Vice President of Equity ResearchDaniel Markowitz - Equity Research AssociateGerardo Hernandez - CFOLaine Morgan - Associate VPWaleed Hassanein - President and CEONone - Company RepresentativeConference Call ParticipantsChris Pasquale - Partner and Senior Analyst of Medical Devices and SuppliesDavid Rescott - Senior Research AnalystJosh Jennings - Managing Director and Senior AnalystMatthew ...